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Abstract
Background: Trachyspermum ammi, commonly known as Ajwain, is a member of the Apiaceae family. It is a therapeutic herbal spice with diverse pharmacological properties, used in traditional medicine for various ailments. However, all previous studies were conducted using small molecule extracts, leaving the protein’s bioactivity undiscovered.
Aim: The current study aimed to demonstrate the cytotoxic activity of Ajwain non-specific lipid transfer protein
(nsLTP1) in normal breast (MCF10A), breast cancer (MCF-7), and pancreatic cancer (AsPC-1) cell lines. Also, to evaluate
its structural stability in human serum as well as at high temperature conditions.
Methods: The cytotoxic activity of Ajwain nsLTP1 was evaluated in MCF-7 and AsPC-1 cell lines using MTT assay.
Annexin V-FITC and PI staining were used to detect the early apoptotic and late apoptotic cells. The role of nsLTP1
in inducing apoptosis was further studied by quantifying Bcl-2, Bax, Caspase-3, Survivin, EGFR, and VEGF genes
expression using RT-PCR. CD spectroscopy analyzed the nsLTP1 conformational changes after thermal treatment for
structure stability determination. The RP-HPLC was used to analyze the nsLTP1 degradation rate in human serum at
different time intervals incubated at 37 °C.
Results: Ajwain nsLTP1 showed a potent cytotoxic effect in MCF-7 and AsPC-1. The IC50 value obtained in MCF-7
was 8.21 μM, while for AsPC-1 4.17 μM. The effect of nsLTP1 on stimulating apoptosis revealed that the proportions
of apoptotic cells in both cell lines were relatively increased depending on the concentration. The apoptotic cells
percentage at 20 μM was in MCF-7 71% (***P < 0.001) and AsPC-1 88% (***P < 0.001). These results indicate that nsLTP1
might efficaciously induce apoptosis in multiple types of cancerous cells. Genes expression in MCF-7 and AsPC-1
showed significant upregulation in Bax and Caspase-3 and downregulation in Bcl-2, Survivin, EGFR, and VEGF protein.
The CD analysis of nsLTP1 showed a significant thermostable property. In serum, nsLTP1 showed a slow degradation
rate, indicating high stability with a half-life of ~ 8.4 h.
Conclusion: Our results revealed the potential anticancer activity of Ajwain nsLTP1 and its mechanism in inducing
apoptosis. It further exhibited thermostable properties at high temperatures and in human serum, which suggested
this protein as a promising anticancer agent.
Keywords: Ajwain seeds, Protein, nsLTP, Anticancer activity, Apoptosis, Serum stability, CD spectroscopy, Flow
cytometry
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Background
Life-threatening diseases have become one of the most
global healthcare concerns [1]. However, cancer is still
one of the most significant causes of death with high
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morbidity and mortality. According to International
Agency for Research on Cancer, the globally estimated
number of cancer cases in 2020 was 19.3 million. In 112
countries, cancer is considered the first leading cause
of death in the young population, with almost 10 million deaths in 2020 [2]. Additionally, the United States
alone has 1,806,590 new cancer cases and 606,520 cancer deaths in the last year. Among different cancer types,
breast cancer is the most diagnosed cancer in women,
with 2.3 million new cases in 2020 [3]. Moreover, it has
been reported that breast cancer families with BRCA1
and BRCA2 mutations have been linked to an increased
risk of pancreatic cancer [4]. Despite all advanced technologies and new treatment approaches, the cancer survival rate is still very low for multiple types, including the
pancreas (9%) [3].
Circumvention of apoptosis is a common feature of all
malignant cells. There is an imbalance between cell division and cell death in cancerous cells due to sequential
genetic changes and alterations in the signal transduction pathways resulting in deregulation of the apoptosis process [5, 6]. Understanding the apoptosis process
is extremely important because it gives insight into
the pathogenesis of disease and the possible treatment
mechanisms. Apoptosis is a programmed mechanism of
cell death activated in response to cell stress or growth
factor deprivation. It is initiated by either the mitochondrial (intrinsic) pathway or the death receptor (extrinsic)
pathway [7]. Both paths lead to the activation of caspases,
which are responsible for DNA and protein breakdown.
Therefore, down-regulation of anti-apoptotic proteins
and up-regulation of proapoptotic proteins will enhance
anticancer activity by inducing apoptosis [8]. Current
treatment approaches such as surgery, radiation, and
small molecules chemotherapy have massive side effects,
which demand researchers and pharmaceutical industries to develop a new effective treatment with fewer
adverse effects. Protein-based drugs extracted from
plants and other natural organisms might have a significant role in drug development and the discovery for new
cancer agents [9–11].
Based on multiple reports, nonspecific Lipid Transfer
Proteins (nsLTPs) possess anticancer activities against
several cancer types. Plant nsLTPs are cysteine-rich proteins classified based on their molecular mass into two
subfamilies, nsLTP1 (9–10 kDa) and nsLTP2 (6–7 kDa)
[12]. Their structure is stabilized by four disulfide bonds
formed between eight cysteine residues [13]. Functionally, they are characterized by their ability to bind with
lipid molecules and transfer them between membranes.
They are also involved in the plant’s innate immunity,
especially the signaling pathways [14]. Both nsLTPs
were successfully purified and characterized from
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various plants species [15–22]. In the in-vitro experiments, nsLTPs from fennel seeds (Foeniculum vulgare)
and cole seeds (Brassica campestris) showed anticancer activity against breast cancer cell line (MCF-7) [23,
24]. In addition, the cytotoxic effect of nsLTP isolated
from Peganum harmala seeds has been observed in four
cancer cell lines, including melanoma (B16), esophagus
carcinoma (Eca-109), gastric carcinoma (MGC-7), and
cervical carcinoma (HeLa) [25]. Despite all discovered
nsLTPs from different plants, their cytotoxic activity
studies remain limited. Previously, we have reported the
extraction, purification, amino acid sequence, and molecular modeling of nsLTP from Ajwain seeds [26]. The
complete primary structure established is deposited to
the UniProt Knowledgebase under the accession number
C0HLG2,
https://www.uniprot.org/uniport/C0HLG2.
Subsequently, our in silico investigation presents 3D
modeling, docking patterns, and dynamic interactions
of Ajwain nsLTP1 with different ligands. The coordinate
file of Ajwain nsLTP1 is submitted to the online protein model database (PMDB). The PMDB ID of the submitted model is PM0081852. This study evaluates the
nsLTP1 cytotoxic activity extracted from Ajwain (Trachyspermum ammi L.) seeds. The Ajwain is also known
as ajowan, caraway, bishop’s weed, or carom seeds. It
belongs to the plant family Umbelliferae or Apiaceae.
Members of this family are well known for their therapeutic properties. In traditional medicine, Ajwain seeds
are commonly used to relieve various ailments such as
colic, dyspepsia, and diarrhea [27]. Also, previous experiments showed pharmacological properties, including
antibacterial [28, 29], antifungal [30], anthelmintic [31],
antihypertensive, hepatoprotective [32], anti-inflammatory [33], and antioxidant [34]. However, all explored bioactive properties of Ajwain seeds were based on aqueous,
acetonic, ethanolic, methanolic, and essential oil extracts,
leaving the proteins and peptides undiscovered [35].
Therefore, this study is focused on evaluating nsLTP1
cytotoxic activities in breast cancer (MCF-7) and pancreatic cancer (AsPC-1) cell lines, quantified the expression of pro- and anti-apoptotic genes to investigate the
ability of nsLTP1 in inducing apoptosis and its anticancer mechanism. Furthermore, the stability of nsLTP1 in
human serum was evaluated in an in-vitro assay and its
secondary conformations at different temperatures using
circular dichroism (CD) spectroscopy.

Materials and methods
Ajwain seeds were deposited and authenticated based
on morphology by Dr. Muneeba Khan, Taxonomist at
the Center for Plant Conservation, University of Karachi
Herbarium and Botanical Garden. As per institutional
policy, seeds are not accepted as a voucher specimen, but
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no deposition number is issued, required for the whole
plant.
Extraction and purification of nsLTP protein

The extraction and the purification of nsLTP from defatted Ajwain seeds have been reported previously [26]. The
purified nsLTP protein was further characterized for the
secondary protein structure, serum stability and evaluated in vitro cytotoxic activities in two different cancer
cell lines and a normal cell line.
Normal and cancer cell culture

Human breast cancer MCF-7 (ATCC HTB-22), pancreatic cancer AsPC-1 (ATCC CRL-1682), and normal
breast MCF10A (ATCC CRL-10317) cell lines (ATCC,
Manassas, USA) were cultured at 37 °C with 5% CO2. The
MCF-7 cancer cells were maintained in Dulbecco’s Modified Eagle Medium (DMEM) and AsPC-1 in the Roswell
Park Memorial Institute (RPMI) mediums, supplemented with 10% (v/v) of fetal bovine serum (FBS) and
1% (v/v) penicillin-streptomycin. The normal breast cells
MCF10A was maintained in mammary epithelial cell
basal medium (MEBM), supplemented with mammary
epithelial cell growth medium (MEGM) growth factors
(Lonza, USA).

Page 3 of 11

Apoptosis assay by flow cytometry

Cell apoptosis detection assay was performed using a
commercially available kit (FITC Annexin V Apoptosis
Detection Kit II, BD Biosciences, USA) as per the manufacturer’s instructions. We used three different concentrations to see if the degree of apoptosis is affected
by changing the concentration. Briefly, 2.5 × 105 cells
per 2 mL were seeded in each well in a 6-well plate and
were allowed to adhere to the bottom of the plate for
24 h in the incubator at 37 °C in a humidified atmosphere of 5% CO2. After 24 h, the cells were inspected
for their health and confluency. After that, the cells
were treated with nsLTP1 (5, 10, and 20 μM) for 48 h.
The untreated cells served as control. After 48 h treatment, the cells were harvested and centrifuged at 1500
RPM. The pellet was washed twice using cold PBS and
resuspended using the 1X binding buffer. Annexin V
(5 μL) and propidium iodide (PI) (5 μL) were mixed
with 100 μL of the suspended cells in a culture tube, followed by 15 min incubation at room temperature in the
dark. The mixture was diluted by adding 400 μL of the
1X binding buffer and immediately analyzed using flow
cytometry, FACS Verse (BD Biosciences, USA). This
experiment was repeated independently three times in
triplicate [37].

Cell survival assay using MTT

The cytotoxic effect was determined using purified
nsLTP1 by RP-HPLC. The sample was concentrated,
and the protein concentration was estimated by Bradford assay. The sample for cell culture was prepared in
the respective medium and evaluated using MTT [3-(4,
5-dimethylthiazol-2-yl)-2, 5-diphenyl tetrazolium bromide] assay [36]. In 96 well plates, 200 μL of medium
containing 10,000 cells/well were seeded and incubated
for 24 h at 37 °C with 5% CO2. The medium was removed
the next day, and different concentrations (2.5, 5, 10, 15,
and 20 μM) of purified nsLTP1 were used to treat the
cells and calculated the IC50 for both cell lines. The Doxorubicin was used as a positive control, whereas untreated
cells were control cells in this experiment. After 48 h
incubation, the treatments were replaced with MTT
dye (0.5 mg/mL in medium), followed by 4 h incubation
at 37 °C and 5% CO2. After discarding the dye, 100 μL
DMSO was added to solubilize the purple-blue colored
formazan crystal. SpectraMax M5 Microplate Reader
was used to measure the absorbance at 550 nm. This
experiment was repeated three times in triplicate, and
the following equation was used to calculate the percentage of inhibition:

%Inhibition =

RNA extraction, cDNA synthesis, and gene expression
quantification

MCF-7 and AsPC-1 cells were seeded in 6-well plates at
a density of 2.5 × 105 cells/well for 24 h. The cells were
treated with different concentrations of nsLTP1 (5, 10,
and 20 μM) for 48 h. TRIzol reagent (Invitrogen, USA)
was used to extract mRNA according to the manufacturer’s protocol. The RNA concentration was quantified
using a NanoDrop spectrophotometer (Thermo Fisher
Scientific, USA). The yields were approximately 2 μg
from each cell line which were reverse transcribed to
cDNA using the RevertAid First Strand cDNA synthesis kit (Thermo Fisher Scientific). The cDNA was used
to quantify Bcl2, BAX, caspase-3, surviving, EGFR,
and VEGF gene expressions by Real-Time Polymerase
Chain Reaction (RT-PCR). Reactions were performed
using Maxima SYBR Green/ROX qPCR master mix kit
(Thermo Fisher Scientific) in QuantStudio 3 Real-Time
thermocycler (Applied Biosystems, Thermo Fisher Scientific) under the following conditions: 95 °C for 10 min
followed by 40 cycles of 95 °C for 15 s and 55 °C for
60 s. GAPDH was used as the housekeeping gene. Fold
change in gene expression was calculated using the

Absorbance of control − Absorbance of treated cells
x100
Absorbance of control
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2-ΔΔCt method and presented as the mean ± SD relative
to control cells in three independent triplicate experiments [38].
Circular Dichroism (CD) spectroscopy

MilliQ water was used to make a 50 μM concentration of nsLTP1 for the CD spectroscopy analysis. MilliQ water background-subtracted CD spectra were
recorded using a JASCO J-1500 spectropolarimeter
equipped with the Peltier Jasco PTC-510 temperature
controller (Jasco Corp., Japan) under the following
conditions: Nitrogen flow 20 SCFH, PM-539 detector,
data interval 0.1 nm, data pitch 0.1 nm, CD scale 200
mdeg/0.1 dOD, FL scale 200 mdeg/0.1 dOD, bandwidth
1 nm, cell length 1 mm, start mode immediately, scanning mode continuous, scanning speed 50 nm/min,
and shutter control auto. An average of three readings
between 190 and 260 nm was collected for each sample. The sample was scanned at 20, 40, 60, 80, and 95 °C
for 20 min, and then cooled to 20 °C for 20 min before
being scanned again. Under the same conditions and
parameters, collagen was used as a control to compare
the conformational changes in the secondary structure
after thermal treatment. Analysis was carried out using
one of the multivariate regression analyses, Principal
Component Regression (PCR), with a basis set containing 26 proteins reference set under the following conditions: standardization of result 100, replaced negative
value to zero, and rejection percentage 1%.
In vitro stability assay in human serum and medium
containing FBS

Analytical RP-HPLC was used to analyze the nsLTP1
stability studies in human serum (MP Biomedicals,
USA) and medium containing FBS. Human serum 25%
in water and the cell culture medium containing 10%
FBS were mixed with 20 μM of nsLTP1 and incubated at
37 °C, respectively. At different time intervals (0, 3, 6, 12,
24, 48, and 72 h), several aliquots (100 μL) were diluted
in 200 μL cold methanol and kept for 10 min on ice to
precipitate the proteins. The samples were centrifuged
at 10000 RPM for 10 min; the supernatant was injected
into Aeris Widepore-C4 particle size 3.6 μm, pore size
200 Å (250 × 4.6 mm) column running with a gradient
0–60% acetonitrile with 0.1% trifluoroacetic acid (TFA)
in 65 min. The elution flow rate was 1 mL/min, and the
absorbance was detected at 214 nm. The degradation of
nsLTP1 was confirmed by measuring the area under the
curve (AUC) after each run.
Statistical analysis

GraphPad Prism 9.3.1 software (La Jolla, CA, USA) was
used to analyze the experimental data. One-way ANOVA
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(analysis of variance) was used for group comparison,
followed by Dunnett’s post-hoc test to determine the
statistical significance. Results with P values of < 0.05
were considered statistically significant and presented as
*P < 0.05, **P < 0.01, ***P < 0.001.

Results
Cytotoxic effect of nsLTP1

The activity of purified nsLTP1 from Ajwain seeds
against normal breast cell line MCF10A and cancer cell
lines MCF-7 and AsPC-1 were evaluated using the MTT
assay. The nsLTP1 concentration in the sample was determined by Bradford assay and screened at different doses
(2.5, 5, 10, 15, and 20 μM). In a dose-dependent manner,
our results showed a potent cytotoxic effect in MCF-7
and AsPC-1 compared to the control cells (Fig. 1A). After
48 h treatment, the 20 μM dose significantly suppressed
the survival of MCF-7 and AsPC-1 by 80% (***P < 0.001)
and 89% (***P < 0.001), respectively. The IC50 concentrations were calculated using nonlinear regression analysis; for MCF-7, the value was 8.21 ± 0.79 μM, while for
AsPC-1, 4.17 ± 0.34 μM, indicating that nsLTP1 shows a
more cytotoxic effect against the pancreatic cancer cells
compared to the breast cancer cells. However, the inhibition effect on MCF10A at a higher dose (20 μM) was
estimated as 23%. Contrary to cancer cells, nsLTP1 did
not exhibit the same degree of cytotoxicity against normal cells (Fig. 1A). Also, a dose-dependent inhibition was
observed for doxorubicin (positive control) in all cell lines
with IC50 values of 0.4224 ± 0.03 μM (MCF-7) 0.2786 ±
0.01 μM (AsPC-1), and 0.3767 ± 0.02 μM (MCF10A) as
shown in Fig. 1B.
Proapoptotic effects of nsLTP1

To investigate the role of nsLTP1 in inducing apoptosis,
MCF-7 and AsPC-1 cells were treated with various concentrations (5, 10, and 20 μM) and without nsLTP1 for
48 h. Apoptosis was detected using Annexin-V and Propidium Iodide (PI) staining, and the number of apoptotic
cells was counted in the lower right (early apoptosis)
and upper right (late apoptosis) quadrants. As depicted
in Fig. 2A & B, the proportions of apoptotic cells in both
cell lines were relatively increased depending on the concentration. In comparison with control, the apoptotic
cells percentage at 20 μM was increased significantly
in MCF-7 to 71% (***P < 0.001) (Fig. 2C) as well as in
AsPC-1 to 88% (***P < 0.001) (Fig. 2D). At lower concentrations, a slight difference in the degree of apoptosis was
observed in both cell lines, which may be due to differences in cancer cell types. For instance, in MCF-7 cells,
there is more apoptosis observed (***P < 0.001) compared
to AsPC-1 (**P < 0.01). Overall, we can safely conclude
that nsLTP1 can induce apoptosis in multiple types of
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Fig. 1 Dose-dependent cytotoxic activity of Ajwain nsLTP1 after 48 h treatment. Data from three independent experiments are presented with
mean and standard deviation (SD) highlighted as *P < 0.05, **P < 0.01, ***P < 0.001. A nsLTP1 calculated IC50 values in MCF-7 and AsPC-1 were
8.21 μM and 4.17 μM, respectively. The pecentage of cells inhibition in MCF10A was 23% at 20 μM dose compared to the control. B Doxorubicin
calculated IC50 values, 0.4224 ± 0.03 μM in MCF-7, 0.2786 ± 0.01 μM in AsPC-1, and 0.3767 ± 0.02 μM MCF10A

cancerous cells. The data were presented as the mean ±
SD of three independent experiments.
Effect of nsLTP1 on the expression of apoptosis‑related
genes

Further analysis was performed to explore the mechanism of nsLTP1 in inducing apoptosis in MCF-7 and
AsPC-1. The gene expression of proapoptotic (Bax and
Caspase-3) and cancer-associated genes which promote cell survival (Bcl-2, Survivin, EGFR, and VEGF)
were analyzed in RT-PCR (Fig. 3). In MCF-7, a significant upregulation fold change was observed in Bax

and Caspase-3 by 1.4-fold (**P < 0.01) and 1.5-fold
(***P < 0.001), respectively, at 20 μM dose. Also, the
same dose significantly caused downregulation in Bcl2, Surviving, EGFR, and VEGF genes by 0.5, 0.5, 0.7,
and 0.4 fold, respectively (Fig. 3A). In congruence with
the MCF-7 findings, Bax in AsPC-1 cells was upregulated significantly by 1.2-fold (**P < 0.01); also, in Caspase-3, the fold change was noted at a significant level
of 1.3-fold (***P < 0.001). On the other hand, we noted a
significant downregulation in the fold change of Bcl-2,
Surviving, EGFR, and VEGF genes by 0.6, 0.7, 0.1, and
0.2 fold, respectively (***P < 0.001), as shown in Fig. 3B.
All the above data were compared to control cells.

Alshammari et al. BMC Complementary Medicine and Therapies

(2022) 22:135

Page 6 of 11

Fig. 2 The apoptotic effect of Ajwain nsLTP1 using Annexin V-FITC/PI staining by flow cytometry. Live cells (Annexin V−, PI−), early apoptotic
cells (Annexin V+, PI−), late apoptotic cells (Annexin V+, PI+), and necrotic cells (Annexin V−, PI+), (A) MCF-7 (B) AsPC-1 cells. The percentage
of apoptosis among different concentration treatments is represented in MCF-7 cells (C) and AsPC-1 cells (D) compared to control cells. The sum
of early apoptotic and late apoptotic cells was considered as the percentage of apoptosis. The data were presented as the mean ± SD of three
independent experiments and significance are indicated by *P < 0.05, **P < 0.01, ***P < 0.001

Effect of thermal treatments on nsLTP1 secondary
structure

CD spectroscopy was used to investigate the stability of nsLTP1 at various temperatures. The spectra
were recorded for nsLTP1 and the control (collagen)
at temperatures ranging from 20 to 95 °C temperatures and after cooling to 20 °C, as shown in Fig. 4.
The estimated secondary structure contents of the
protein from Principal Component Regression (PCR)
of the CD spectra indicated significant proportions of

α-helical structure, as demonstrated in Table 1. The
nsLTP1 showed the thermostable property. There
were minimal changes in the secondary structure at
95 °C and after cooling down to 20 °C. The spectra
before and after heating at 20 °C were almost similar.
The positive maxima at 191 nm and double minima
at 220 nm and 209 nm were the unique signatures of
the protein (Fig. 4A). PCR analysis indicated a much
lower content of β-sheet (21.9%) and turn (11.2%)
compared to α-helix (32.4%) and other (34.5%) at
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Fig. 3 Ajwain nsLTP1 mechanism of action in inducing apoptosis in MCF-7 and AsPC-1. Both cell lines were treated with the same concentrations
and compared to control cells. A In MCF-7, nsLTP1 promoted apoptosis by increasing the gene expression of proapoptotic proteins (Bax and
Caspase-3) and decreasing the anti-apoptotic protein (Bcl-2). Also, it decreased the expression of other cancer-associated genes that promote cell
survival, including, Survivin, EGFR, and VEGF. B In AsPC-1, nsLTP1 promoted apoptosis by upregulation of the gene expression of Bax and Caspase-3,
and downregulation of Bcl-2, Survivin, EGFR, and VEGF. All data were obtained from three independent experiments and significance are indicated
by *P < 0.05, **P < 0.01, ***P < 0.001

20 °C. Therefore, the CD spectrum of nsLTP1 implies
a rich protein in α-helix. When heated to 95 °C, the
maxima and minima decreased in intensity, reporting
PCR analysis of β-sheet (2.5%), turn (15.5%), α-helix
(43.1%), and other (38.9%). PCR analysis indicated an
increase in α-helix and a corresponding decrease in
β-sheet structure at 95 °C. After cooling down back to
20 °C, the spectrum almost matched the before heating, retaining native-like α-helix and β-sheet structures. In contrast, collagen was denatured as the
temperature increased to 40 °C and remained denatured even after cooling it down to 20 °C (Fig. 4B). The
data suggest that the Ajwain nsLTP1 is resistant to
thermal denaturation, which only explains small conformational changes.

In vitro stability assay in human serum and medium
containing FBS

The stability of nsLTP1 was evaluated at 37 °C with a
human serum to mimic the in vivo environment (Fig. 5)
and with the cell culture medium containing 10% FBS
(Supplementary Fig. S1). NsLTP1 showed high stability in human serum with a half-life of ~ 8.4 h at specific
incubation time points ranging from 0 to 72 h, as illustrated in Fig. 5A. At 3 h incubation time, the remaining sample was 75% ± 4%, confirming the high stability.
While, at 72 h, almost all the sample was degraded with a
remaining portion of 2% ± 1%. The peak areas at a retention time of 36 min confirmed the slow degradation rate
of nsLTP1 (Fig. 5B). Also, nsLTP1 was stable in the cell
culture medium containing 10% FBS with an estimated
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Fig. 4 The thermal treatments effect on Ajwain nsLTP1 secondary structure. Collagen was used as a control in this experiment. A nsLTP1 CD spectra
were collected at 20, 40, 60, 80, 95 °C, and after cooling down to 20 °C. There were minimal changes in the secondary structure at 95 °C; however, it
is back to the original upon cooling it to 20 °C. B collagen was denatured as the temperature increased to 40 °C and remained denatured even after
cooling it down to 20 °C

Table 1 Ajwain nsLTP1 secondary structure estimated by
Principal Component Regression (PCR) analysis of CD spectra
Temperature

α-helix

β-sheet

Turn

Other

Before heating 20 °C

32.4%

21.9%

11.2%

34.5%

40 °C

35.5%

17.8%

12.0%

34.7%

60 °C

38.8%

13.5%

12.9%

34.8%

80 °C

43.1%

7.0%

14.0%

35.9%

95 °C

43.1%

2.5%

15.5%

38.9%

After heating 20 °C

34.9%

18.3%

11.6%

35.2%

half-life of 6.4 h (Supplementary Fig. S2). The remaining
percentage of the sample at 3 h was 85% ± 5%. While, at
72 h, almost all the sample was degraded with a remaining portion of 4% ± 0.5%. The nsLTP1 and human serum
were analyzed independently to confirm their elution
retention times (Supplementary Fig. S3).

Discussion
In 1975, Kader found the first plant nsLTP in potato tuber
[39]. NsLTPs are small, highly soluble, and basic proteins
found abundantly in all land plants. Their three-dimensional structure is stabilized by four disulfide bridges
formed between an eight-cysteine motif (8-CM) in a typical sequence pattern C-Xn-C-Xn-CC-Xn-CXC-Xn-CXn-C [40]. Various hydrophobic molecules such as fatty
acids, fatty acyl-coenzyme A, galactolipids, phospholipids, and phosphatidylglycerol can be transferred between
plant membranes nonspecifically through nsLTPs. These
proteins play a crucial role in many processes in plants,

including stress resistance, defense against pathogen attack,
reproduction, seed germination, and pollen adhesion [13].
However, nsLTPs biological activities are not limited to
plants only; previous reports showed their ability to inhibit
the growth of human tumor cells [23, 24]. Therefore, in this
present study, we investigated the potential cytotoxic activity of nsLTP1 isolated from Ajwain seeds.
For a long period, Ajwain seeds small molecule extracts
have been well known for their pharmacological properties; however, to the best of our knowledge, the macromolecule extracts (especially proteins) have not been
studied for their potential cytotoxic activity against cancer cells. Thus, initially screened the crude proteins and
gel filtration fractions against MCF-7 and AsPC-1; the
preliminary data showed the maximum inhibition percentage occurred by the fractions, which contained the
highest portion of nsLTP1. The purified nsLTP1 exhibited a cytotoxic effect against MCF-7 and AsPC-1 cells.
The calculated IC50 values were 8.21 μM and 4.17 μM for
MCF-7 and AsPC-1, respectively, in comparison to control cells. Moreover, these cytotoxic effects were compared to two nsLTPs previously isolated from Foeniculum
vulgare (tested in MCF-7 with IC50 6.98 μM) and Brassica campestris (tested in MCF-7 and Hep G2 with IC50
1.6 μM and 5.8 μM, respectively) [23, 24]. Results indicate
that nsLTPs from different plants act differently against
various cancer cell lines; conversely, Vigna radiata nsLTP
was inactive against MCF-7. Sequence alignment of these
nsLTPs showed several differences in their amino acid
sequences, which could be the reason for the variable
activity observed.
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Fig. 5 Stability of Ajwain nsLTP1 in human serum. A the percent remaining of nsLTP1 was quantified for specific incubation time points ranging
from 0 to 72 h using the area under the curve (AUC) in analytical RP-HPLC. The trendline gives the half-life of ~ 8.4 h. Each point represents an
average of three independent replicates. B Analytical RP-HPLC profile of nsLTP1 at retention time 36 min in human serum monitored at 214 nm

The previous results were further supported by analyzing the number of apoptotic cells using the flow
cytometric method, which showed consistent results
with the cytotoxicity assay. It is suggested that inducing
apoptosis might be an effective cancer treatment strategy [41]. Our results revealed that nsLTP1 possessed a
significant ability to induce apoptosis in both MCF-7 and
AsPC-1 cells. For MCF-7 cells, as compared to control
cells, nsLTP1 induced apoptosis at concentrations of 5
and 10 μM, almost reaching 50%. Meanwhile, the highest
apoptotic 71% was recorded at 20 μM. At 5 and 10 μM,
nsLTP1 induced apoptosis in MCF-7 cells more than that
observed in AsPC-1 cells. However, at 20 μM, the apoptotic percentage of nsLTP1 in AsPC-1 was higher than
that found in MCF-7 cells compared to control cells, as
shown in Fig. 2A & B.
The mechanism of apoptosis exerted by Ajwain nsLTP1
in MCF-7 and AsPC-1 was further evaluated based on
the gene expression level. We analyzed several genes
associated with tumor growth and its resistance to treatment, including Bcl-2, Bax, Caspase-3, Survivin, EGFR,
and VEGF. The Bcl-2 protein family controls the mitochondrial apoptotic pathway through proapoptotic (Bax)
and anti-apoptotic (Bcl-2) proteins. The Bax/Bcl-2 ratio
imbalance will prevent the activation of executioner Caspase-3, which is essential in initiating downstream substrates cleavage involved in apoptotic changes [42]. This
study observed a significant upregulation in Bax and
Caspase-3 and downregulation in Bcl-2 after nsLTP1
treatment, indicating apoptosis activation in MCF-7
and AsPC-1. Survivin, a member of the inhibitor of

apoptosis protein (IAP) family, inhibits caspases activation, which eventually leads to the inactivation of the
apoptosis process. Survivin is highly expressed in cancer
cells and fetal tissue; however, in terminally differentiated cells is undetected. Its effect on angiogenesis promotion is associated with its capability to promote vascular
endothelial growth factor (VEGF) in cancer cells, which
is considered a rate-limiting step in tumor growth [43]. In
addition, epidermal growth factor receptor (EGFR) overexpression enhances Survivin expression in cancer cells
through the phosphoinositide 3-kinases pathway [44].
Based on these findings, Survivin could potentially offer
a new cancer therapeutic target distinguishing between
transformed and normal cells [45]. The results showed
that at the highest concentration (20 μM), nsLTP1 exhibited a significant upregulation of the expression levels of
Bax and Caspase-3 genes in MCF-7 cells, compared to
the control cells. Conversely, nsLTP1 possessed a downregulation effect towards the expression levels of Bcl-2,
Surviving, EGFR, and VEGF genes. Regarding AsPC-1
cells, Bax and Caspase-3 genes expression levels were significantly upregulated by the action of nsLTP1; however,
Bcl-2, Survivin, EGFR, and VEGF genes expression were
downregulated in comparison to the control cells.
Protein-based drugs are becoming more important
due to their ability to treat various diseases. Despite their
unique characteristics, including high activity, strong
specificity, and low toxicity, structural stability is a major
hurdle for the pharmaceutical industries from fastly
developing new therapeutic proteins. For instance, the
high temperature causes conformational changes (unfold)
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in a protein structure, reducing their therapeutic effect or
triggering severe immune responses [46]. Thus, we investigated the thermal stability of Ajwain nsLTP1 using CD
spectroscopy. Interestingly, we found that nsLTP1 is a
highly stable protein at 95 °C temperature, suggesting it
has a melting temperature above 100 °C. In other studies, in situ heating of nsLTP1 from apple reveals that it
unfolds slightly at elevated temperature and refolded
upon cooling [47]., and no major changes were reported
in the structure of LTP1 from barley in the temperature
range of 20 °C to 90 °C [48]. These data are consistent
with observations made regarding the thermostability of
nsLTP1, possibly due to their unique presence of intramolecular disulfide bonds bestowing the characteristic
of thermostability. In addition, after confirming the thermostability properties of nsLTP1, evaluated its stability in
human serum. The estimated half-life was ~8.4 h which
is considered close to the ideal half-life (12–48 h) [49].
Nevertheless, the promising results of Ajwain nsLTP1 in
inhibiting the proliferation of breast and pancreatic cancers could be used for further investigations to prove its
potential bioactive properties in an animal model.

Conclusion
The Ajwain nsLTP1 protein exerts a potential cytotoxic
activity against MCF-7 and AsPC-1 cancer cells and
induces apoptosis via downregulation of anti-apoptotic
proteins and upregulation of proapoptotic proteins. Also,
nsLTP1 exhibited potent stability in high temperatures
and in human serum, which may open an avenue towards
the economic importance of plant protein-based drugs.
However, to further confirm its cytotoxic effects, considering in vivo study is highly warranted.
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half-life was ~ 6.4 h. Each point represents an average of three independent replicates. Supplementary Figure S3. Chromatographic profile of
Ajwain (A) nsLTP1 alone eluted at 36 min (B) Human serum proteins eluted
between 45 and 47 min. Samples were prepared in 100% cold methanol
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